Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Other Gross PP&E Adjustments (2016 - 2025)

Pharma-Bio Serv's Other Gross PP&E Adjustments history spans 14 years, with the latest figure at $286600.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 54.43% year-over-year to $286600.0; the TTM value through Oct 2025 reached $286600.0, down 54.43%, while the annual FY2025 figure was $286600.0, 54.43% down from the prior year.
  • Other Gross PP&E Adjustments reached $286600.0 in Q4 2025 per PBSV's latest filing, up from -$72747.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $628933.0 in Q4 2024 to a low of -$790561.0 in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$253557.0, with a median of -$298574.0 recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 3915.44% in 2022, then crashed 54.43% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $3937.0 in 2021, then soared by 3915.44% to $158088.0 in 2022, then soared by 96.98% to $311408.0 in 2023, then skyrocketed by 101.96% to $628933.0 in 2024, then plummeted by 54.43% to $286600.0 in 2025.
  • Per Business Quant, the three most recent readings for PBSV's Other Gross PP&E Adjustments are $286600.0 (Q4 2025), -$72747.0 (Q3 2025), and -$115259.0 (Q2 2025).